PHIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Phio Pharmaceuticals Corp (PHIO) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock lacks positive momentum, has weak financials, no significant trading trends, and no strong proprietary trading signals. It is better to hold off on investing in this stock at the moment.
The technical indicators suggest a bearish trend. The MACD is negative and expanding downward, RSI is neutral at 45.068, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading close to its support level (S1: 1.02), with resistance levels at R1: 1.692 and R2: 1.9.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
and a significant YoY EPS drop (-71.43%). Technical indicators are bearish.
In Q3 2025, revenue remained at $0 with no growth. Net income improved YoY but is still negative (-$2,392,000). EPS dropped significantly (-71.43% YoY), and gross margin remains at 0%.
No data available for analyst ratings or price target changes.
